Immunoq Therapeutics Inc.
Bellaire, TX
- UEI
- KW12VEXTQXP7
- CAGE
- 886V0
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4313 Cynthia St, Bellaire, TX 77401, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of therapeutic cancer vaccine | National Cancer Institute (NIH) | $395,738 |
Quick answers
Is Immunoq Therapeutics Inc. registered in SAM.gov?
Yes. Immunoq Therapeutics Inc.'s SAM.gov registration is active through January 26, 2027.
What is Immunoq Therapeutics Inc.'s most recent federal award?
Immunoq Therapeutics Inc.'s most recent federal grant award is Development of therapeutic cancer vaccine (R41CA265459), from National Cancer Institute (NIH), on June 6, 2022.
On GovTribe
See Immunoq Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors